TP53 and neoplasm: Together, these findings indicate that Se@MI, through p53 pathway activation, not only triggers direct tumor cell apoptosis but also reprograms the immune contexture by enhancing CTL infiltration and activity while suppressing Treg-mediated immunosuppressive responses, thereby exhibiting dual mechanisms of tumor suppression involving both intrinsic cellular effects and modulation of immune regulation.